Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2001
05/30/2001EP1102786A2 Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments
05/30/2001EP1102785A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES
05/30/2001EP1102784A1 A compound containing a labile disulfide bond
05/30/2001EP1102776A1 Water soluble prodrugs of hindered alcohols or phenols
05/30/2001EP1102763A2 Fsh mimetics for the treatment of infertility
05/30/2001EP1102742A2 Compounds and compositions for delivering active agents
05/30/2001EP1102599A1 Protease inhibitors for use in the treatment of psoriasis
05/30/2001EP1102598A1 Hair growth/maintenance compositions and methods involving the same
05/30/2001EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors
05/30/2001EP1102596A1 Peptide antagonists of zonulin and methods for use of the same
05/30/2001EP1102589A1 Topical compositions comprising an opioid analgesic and an nmda antagonist
05/30/2001EP0925067A4 Composition and method for repairing neurological tissue
05/30/2001EP0914334B1 Process and intermediates for the synthesis of lhrh antagonists
05/30/2001EP0859785B1 Cyclic peptide analogs of somatostatin
05/30/2001EP0730607B1 Novel integrin-binding peptides
05/30/2001EP0721586B1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders
05/30/2001EP0721468B1 Platelet aggregation inhibitory peptides
05/30/2001EP0656778B1 Enantiomerically pure beta-d-dioxolane-nucleosides
05/30/2001EP0621788B1 Hemoregulatory peptides
05/30/2001CN1297664A Method for controlling connections to mobile station
05/30/2001CN1297486A Anti-viral vectors
05/30/2001CN1297484A Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
05/30/2001CN1297483A Human protease and use of such protease for pharmaceutical applications and for reducing allergenicity of non-human proteins
05/30/2001CN1297481A Introduction of naked DNA or RNA encoding non-human vertebrate peptide hormones or cytokines into non-human vertebrate
05/30/2001CN1297480A Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
05/30/2001CN1297479A Modified adenovirus contg. fiber replacement protein
05/30/2001CN1297454A Novel omega-conotoxin peptides
05/30/2001CN1297453A Certain thiol inhibitors of endothelin-converting enzyme
05/30/2001CN1297452A Modified factor VIII
05/30/2001CN1297357A Preventives or remedies for inflammatory intestinal diseases contg. as active ingredient IL-6 antagonists
05/30/2001CN1297356A Matrix protein compositions for wound healing
05/30/2001CN1297355A Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives
05/30/2001CN1297354A Dipeptide caspase inhibitors and use thereof
05/30/2001CN1297053A Polypeptide-human ubiquitin C-end hydrolase 28 and polynucleotide for coding said polypeptide
05/30/2001CN1297052A Polypeptide-human RNA unwinding enzyme 43 and polynucleotide for coding said polypeptide
05/30/2001CN1297051A Polypeptide-human phosphatase 79 and polynucleotide for coding said polypeptide
05/30/2001CN1297050A Polypeptide-human phosphatidic acid phosphatase 2-35 and polynucleotide for coding said polypeptide
05/30/2001CN1297049A Polypeptide-human cyclophosphate guanine suppressed phosphodiesterase 17 and polynucleotide for coding said polypeptide
05/30/2001CN1297047A Polypeptide-human protein phosphatase 1 regulatory protein 68 and polynucleotide for coding said polypeptide
05/30/2001CN1297046A Polypeptide-human branched chain transacylase 31 and polynucleotide for coding said polypeptide
05/30/2001CN1297045A Polypeptide-human UCT-isoenzyme 28 and polynucleotide for coding said polypeptide
05/30/2001CN1297044A Polypeptide-human methionyl tRNA synthetase 29 and polynucleotide for coding said polypeptide
05/30/2001CN1296975A Polypeptide-human ribosomal protein L23 and polynucleotide for coding said polypeptide
05/30/2001CN1296974A Polypeptide-human histone H2A.21 and polynucleotide for coding said polypeptide
05/30/2001CN1296973A Polypeptide-human calbindin No.42 and polynucleotide for coding said polypeptide
05/30/2001CN1296970A Polypeptide-human actin-binding protein 54 and polynucleotide for coding said polypeptide
05/30/2001CN1296968A Polypeptide-human karyon regulatory protein 56 and polynucleotide for coding said polypeptide
05/30/2001CN1296967A Polypeptide-human deaf related gene 14 and polynucleotide for coding said polypeptide
05/30/2001CN1296966A Polypeptide-human SR splicing factor 52 and polynucleotide for coding said polypeptide
05/30/2001CN1296964A Polypeptide-human Yip44 and polynucleotide for coding said polypeptide
05/30/2001CN1296962A Polypeotide-zinc finger protein 79 and polynucleotide for coding said polypeptide
05/30/2001CN1296959A Polypeptide-human FD23 and polynucleotide for coding said polypeptide
05/30/2001CN1296957A Polypeptide-murine tricarboxylic acid vector 39 and polynucleotide for coding said polypeptide
05/30/2001CN1296956A Polypeptide-human Ras bindin 66 and polynucleotide for coding said polypeptide
05/30/2001CN1066345C Growth hormone releasing factor analogs
05/30/2001CN1066329C Preparation of drug composition
05/29/2001US6239270 Nucleic acids encoding human calcium sensor protein
05/29/2001US6239268 Nucleotide and amino acid sequences; recombinant culture production; antibodies; primers; probes; diagnosis and treatment of rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, myasthemia gravis, scleroderma
05/29/2001US6239267 Nucleotide sequence of ion channel protein associated with capsaicin; diagnosis and treatment of nervous system disorders, incontinence, stroke; antiischemic agents; antiarthritic/antiinflammatory agents; analgesics
05/29/2001US6239265 Oligonucleotides having chiral phosphorus linkages
05/29/2001US6239261 Pasteurized, purified von Willebrand factor concentrate and a process for the preparation thereof
05/29/2001US6239259 Multivalent and multispecific antigen-binding protein
05/29/2001US6239258 Human Nkx-2.2 polypeptide-encoding nucleotide sequences
05/29/2001US6239257 Family of proteins belonging to the pancreatic ribonuclease a superfamily
05/29/2001US6239256 Isolated muteins of proteins SCP-1, and compositions containing the mutein
05/29/2001US6239176 Administering to treat blood disorders like anemia; wound healing, anticarcinogenic and antiproliferative agents; genetic disorders
05/29/2001US6239172 Mixture of angiogenic growth factor and l-arginine; brain and cardiovascular disorders
05/29/2001US6239167 Antitumor compositions containing taxane derivatives
05/29/2001US6239150 Penicillaminamide derivatives
05/29/2001US6239137 Salts of aminoimidazole carboxamide and 5 amino or substituted amino 1,2,3-triazole, induce apoptosis, inhibit DNA synthesis and control cyclooxygenase activity
05/29/2001US6239124 Pharmaceutical compositions for the treatment of transplant rejection or autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxyethyl)-rapamycin
05/29/2001US6239117 Dna sequence encoding protein, expression, treating erectile dysfunction, bladder dysfunction, and other smooth muscle disorders.
05/29/2001US6239113 Topical treatment or prevention of ocular infections
05/29/2001US6239111 Drug for treating brain diseases, enables prevention or treatment of dementia and similar diseases caused by degeneration or sloughing of neurons, an ally sulfide, sulfoxide or sulfone
05/29/2001US6239110 Synthetic analogs of thrombospondin and therapeutic use thereof
05/29/2001US6239109 Method of promoting erythropoiesis
05/29/2001US6239108 Cell adhesion inhibitors
05/29/2001US6239107 Treatment of male impotence or treatment of neurodegenerative diseases
05/29/2001US6239106 Family of protease inhibitors, and other biologic active substances
05/29/2001US6239105 Used in modulating insulin-like growth factor levels in serum of patient, modulating lean body mass of patient
05/29/2001US6239104 Isolated and purified substance which inhibits neoplastic cell growth denominated dolastatin 16
05/29/2001US6239102 Concentrate comprising, as active agent, (3'-desoxy-3-oxo-mebmc)1-(val)2-cyclosporin, stabilizer selected from oleic acid or palmitoyl oleoyl phosphatidyl glycerol or salts thereof, ethanol
05/29/2001US6239101 Thrombin binding polypeptides
05/29/2001US6239100 Isolated polypeptide capable of fish growth promoting activity and comprising specified amino acid sequence
05/29/2001US6239099 Methods of treating viral infections
05/29/2001US6238921 Antisense oligonucleotide modulation of human mdm2 expression
05/29/2001US6238918 DNA sequence encoding the tumor suppressor gene ING1
05/29/2001US6238917 Polynucleotides
05/29/2001US6238915 Protein for the treament of preferential genetic disorders
05/29/2001US6238914 Nucleic acid
05/29/2001US6238902 Protein tyrosine phosphatases
05/29/2001US6238900 Nucleotide sequence coding enzymatic polypeptide; for the prevention of bacterial infections; bactericides
05/29/2001US6238890 Single chain forms of the glycoprotein hormone quartet
05/29/2001US6238889 Amino acid sequence of interleukin-3; recombinant culture production
05/29/2001US6238888 Keratinocyte growth factor-2 formulations
05/29/2001US6238887 Ribosome recycling factor (FRR) of Staphylococcus aureus
05/29/2001US6238882 Nucleotide sequence from streptococcus; diagnosis; drug screening for new bactericides; primers; probes; antibodies; vaccines
05/29/2001US6238881 Nucleotide sequence which codes for p115 rho-guanine exchange factor involved in cell signalling; therapeutics; diagnostics; recombinant culture production; antibodies; probes
05/29/2001US6238875 Immunoassay diagnosis of chronic lymphocytic leukemia in humans by detecting and quantitating gene expression of effector cell protease receptors on cd5 positive sample cells
05/29/2001US6238861 Neurofibromatosis gene